Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

The Novo Nordisk Foundation Jacobæus Prize for Biomedicine

Novo Nordisk Fonden

The Jacobæus Prize recognizes an outstanding active scientist within bioscience and basic biomedicine, who at the time of awarding is affiliated with a Danish non-profit research institution and who has contributed with ground-breaking scientific knowledge to advance the understanding of human physiology and/or mechanisms underlying human disease. The Prize is intended to acknowledge scientific excellence and to further strengthen biomedical research in Denmark.

The Prize is of DKK 1.7 million and consists of a DKK 1.250.000 research grant and a personal award of DKK 250.000. An additional DKK 200.000 is awarded to the recipient’s host institution for organisation and hosting of a prize symposium within the recipient’s field(s) of research.

Nominations

The nomination call for 2025 is open until late August. 

The Foundation welcomes nominations by individual researchers and by research institutions including academic and industrial institutions, and research funding agencies. To be evaluated by the BBM Committee, nomination must be submitted electronically via the nomination form to be accessed here. The nomination and review processes are confidential.

Prize Lecture and Ceremony

After official announcement of the Prize, the recipient together with his/her workplace organises and hosts a scientific symposium where the prize recipient introduces his/her research for 30-40 minutes. Moreover, other scientists within relevant areas of research can be invited to present their work at the symposium. One or more representative(s) from the Novo Nordisk Foundation as well as from the BBM Committee must be invited to the prize symposium.

History of the Jacobæus Prize

The Jacobæus Prize – the Foundations oldest prize – was instituted in 1939 by Nordisk Insulin Foundation. It was awarded for the first time in 1942 in memory of H.C. Jacobæus, who served on the Board of the Nordisk Insulin Foundation from its inception in 1926 until his death. Jacobæus was a Swedish professor and pioneering clinical researcher, who developed a method for exploring the pleural cavity (thoracoscopy) using a cystoscope, which greatly improved the diagnosis and treatment of lung diseases, especially tuberculosis.

In 2024, it was decided to change the prize to be national and to broaden the scope to cover all elements of bioscience and biomedicine. From 2025, the Jacobæus prize is therefore awarded for a Danish contribution.

Specialties

Biomedical Engineering

Eligibility Requirements

Nominees must demonstrate scientific excellence that has led to a major discovery or breakthrough in the understanding of human health and disease.
Nominees must have a current position and an active research program at a non-profit research institution in Denmark.
Nominees must serve as inspirational leaders and role models for young scientists.
Nominees may have any nationalities.
Nominators (individual or institution) are limited to one nomination.

Ineligibility:

Self-nominations are not accepted.
Nominators cannot be family members.
The prize may not be awarded to members of the Novo Nordisk Foundation Board or members of one of the Novo Nordisk Foundation standing committees.

The Jacobæus Prize will be announced in December.

Eligible Countries:

Denmark

Sponsor Details

Sponsor Institute/Organizations: Novo Nordisk Fonden

Sponsor Type: Corporate/Non-Profit

Address: Tuborg Havnevej 19 2900 Hellerup Denmark + 45 35 27 66 00 info@novonordiskfonden.dk

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity